Friday, 6 November 2015

Tysabri unsuccessful in secondary progressive MS trial

Source MS Trust:

Preliminary results announced in a press release (link is external) report that treatment with Tysabri did not slow down the gradual increase in disability experienced by people with secondary progressive MS.  Read on.